Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): A multicentre, open-label, phase 2 randomised controlled trial

POPLAR Study Group

Research output: Contribution to journal › Article › peer-review

1535 Scopus citations

Fingerprint

Dive into the research topics of 'Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): A multicentre, open-label, phase 2 randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences